Further studies with our novel mAb KU44.13A in a larger panel of patients’ tumour specimens are warranted and should unravel the relative expression, prognostic significance and predictive value of CD26 in patients with pancreatic cancer as well as other cancer types. The gene discussed is DPP4; the disease is pancreatic neoplasm.